April 1, 2020 CytoDyn sees three more coronavirus patients in New York treated with its drug leronlimab
April 1, 2020 FDA Clears CytoDyn’s Phase 2 Randomized Trial to Treat Mild-to-Moderately Ill Coronavirus Patients with Leronlimab; Enrollment to Begin Immediately
April 1, 2020 CytoDyn sees three more coronavirus patients in New York treated with its drug leronlimab
